LARIMAR THERAPEUTICS, INC.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 4, 2026 10-Q
8-K Aug 4, 2026 8-K
4 Jul 8, 2026 4
8-K Jun 29, 2026 8-K
4 May 20, 2026
4 May 20, 2026 4
4 May 20, 2026 4
4 May 20, 2026 4
4 May 20, 2026 4
4 May 20, 2026 4
8-K May 19, 2026 8-K
SCHEDULE 13G/A May 14, 2026
10-Q May 14, 2026 10-Q
8-K May 14, 2026 8-K
SCHEDULE 13G/A Apr 30, 2026
ARS Apr 20, 2026 ARS
DEF 14A Apr 20, 2026 DEF 14A
PRE 14A Apr 10, 2026 PRE 14A
S-8 Mar 19, 2026 S-8
10-K Mar 19, 2026 10-K
8-K Mar 19, 2026 8-K
8-K Mar 9, 2026 8-K
SCHEDULE 13D/A Mar 2, 2026
4 Mar 2, 2026
4 Mar 2, 2026 4
← Newer Page 1 of 28 · 693 filings Older →